1Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, WHO Collaborating Centre for Research and Training in Tropical Diseases Control, Roma.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Antimalarial drug resistance necessitates combination therapies, particularly artemisinin-based combination therapies (ACTs), to improve efficacy and delay resistance. Challenges in ACT deployment in Africa require strategic implementation for effective malaria control.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: